Treatment-Experienced Genotype 5 or 6

Page Retired 1/21/2021

The following pages include guidance for management of treatment-experienced patients with genotype 5 or 6 infection.

• Peginterferon/Ribavirin-Experienced, Genotype 5 or 6 Patients With or Without Compensated Cirrhosis
• DAA-Experienced (Including NS5A Inhibitors Except Glecaprevir/Pibrentasvir Failures), Genotype 5 or 6 Patients, With or Without Compensated Cirrhosis
• Glecaprevir/Pibrentasvir Treatment Failures (All Genotypes)
• Sofosbuvir/Velpatasvir/Voxilaprevir Treatment Failure (All Genotypes)